Related Experiment Video

Updated: Jul 17, 2026

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

Cardiac morphofunctional injuries in patients with hepatitis C virus: doppler echocardiographic evaluation

Carlos Tosta1, Ricardo Ladeira, Betty Guz

  • 1Hospital do Servidor Público Estadual, São Paulo, SP, Brazil.

Arquivos Brasileiros De Cardiologia
|January 16, 2007
PubMed

Insights

Hepatitis C virus (HCV) patients in early stages show no heart abnormalities. Doppler echocardiography revealed no significant morpho-functional cardiac differences compared to healthy individuals.

Area of Science:

  • Cardiology
  • Hepatology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection can potentially affect multiple organs.
  • Cardiac involvement in HCV is not fully understood, particularly in early disease stages.
  • Doppler echocardiography is a key tool for assessing cardiac structure and function.

Purpose of the Study:

  • To investigate potential morphological and functional cardiac injuries in patients with hepatitis C virus.
  • To compare cardiac parameters between HCV patients and a control group using Doppler echocardiography.

Main Methods:

  • A control-case study design was employed.
  • Doppler echocardiographic parameters were analyzed in 31 patients with HCV and 20 healthy controls.
  • Evaluated metrics included myocardial thickening, ventricular dimensions, ejection fraction, and valve velocities.

Main Results:

  • No significant differences were observed in myocardial thickening between groups.
  • Left ventricular dimensions, circumferential shortening, and ejection fraction showed no significant variations.
  • Mitral valve flow velocities and tissue Doppler parameters (systolic and diastolic) were comparable between HCV patients and controls.

Conclusions:

  • Early-stage hepatitis C virus infection does not appear to cause significant morpho-functional cardiac abnormalities.
  • Doppler echocardiography did not detect cardiac damage in the evaluated cohort of HCV patients.
  • Further research may be needed to explore potential long-term cardiac effects of HCV.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...